Showing 15 posts of 164 posts found.

GSK building

GSK and Vir Biotechnology COVID-19 drug found to reduce deaths and hospitalisation by 85%

March 11, 2021
GSK, GlaxoSmithKline, Vir Biotechnology

Vir Biotechnology and GSK have announced that their monoclonal-antibody drug has been found to reduce hospitalisations or deaths from COVID-19 …

GSK and CureVac sign £132m deal to develop next-generation COVID-19 vaccine

February 3, 2021
Research and Development COVID-19, CureVac, GlaxoSmithKline

GlaxoSmithKline (GSK) and CureVac have today announced they are joining forces to develop a new COVID-19 vaccine to combat future …

NICE recommends GSK’s ZEJULA for advanced ovarian cancer

January 15, 2021
Medical Communications Cancer, GlaxoSmithKline, NICE

NICE has recommended the use of GlaxoSmithKline’s ZEJULA (niraparib) on the NHS in England for adult women with advanced high-grade …


ViiV Healthcare announces authorisation of Europe’s first long-acting HIV injection

December 21, 2020
Sales and Marketing GlaxoSmithKline, HIV, ViiV

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline, has announced the authorisation of Europe’s first complete long-acting …

NICE recommends GSK’s Nucala for more asthma patients

December 18, 2020
Medical Communications GlaxoSmithKline, NICE, asthma, mepolizumab

NICE has today published final draft guidance recommending GlaxoSmithKline’s Nucala (mepolizumab) as an add-on treatment option for severe refractory eosinophilic …


GSK Chief Emma Walmsley voices support for equal pay campaign

October 3, 2019
Medical Communications Emma Walmsley, GSK, GlaxoSmithKline, pharma

GlaxoSmithKline Chief Emma Walmsley has joined the chorus of more than a hundred of the UK’s most successful female business …

GSK teams up with Strathclyde and University of Nottingham

July 16, 2019
Manufacturing and Production GSK, GlaxoSmithKline, UK, britain, pharma, universities

GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at …


GSK to make redundancies at plant in Stevenage

April 17, 2019
Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage

GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …

23andMe to offer genetic reports on diabetes

March 11, 2019
Sales and Marketing 23andME, Genentech, GlaxoSmithKline, Lundbeck, diabetes, genetics, genomics

Personal genomics company, 23andMe will offer customers information on the likelihood that they are genetically predisposed to developing type 2 …

Philip Hampton to step down from chairman role at GSK

January 21, 2019
Sales and Marketing Chairman, GSK, GlaxoSmithKline, appointment, philip hampton

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …


GSK’s anti-seizure drug shows promise in early depression study

November 2, 2018
Medical Communications, Research and Development GSK, GlaxoSmithKline, Potiga, depression, pharma

Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications …


GSK to axe 650 positions across US workforce

September 6, 2018
Manufacturing and Production GSK, GlaxoSmithKline, pharma

GlaxoSmithKline has announced its intention to cut 650 employees from its current US workforce, with the cutbacks coming as part …

GSK appoint HSBC director Iain Mackay as new CFO

August 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Iain Mckay, cfo, hsbc

British pharma giant GlaxoSmithKline have appointed HSBC Group Finance Director, Iain Mackay, as its new Chief Financial Officer. The move …


GSK forges $300m partnership with 23andMe to boost preclinical R&D

July 26, 2018
Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma

In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …


Teva spared payout to GSK over patent infringement dispute

March 29, 2018
Sales and Marketing Coreg, GSK, GlaxoSmithKline, Teva, carvedilol, heart failure, pharma

Teva has been spared a sizeable payout to GlaxoSmithKline after a federal judge overturned a US jury verdict demanding that …

Latest content